Physician profile
Matthew Tran
NPI 1053728956
$8,200.84
in general payments reported to CMS, 2019-2025
31 companies · $1,997 in 2025
The $1,997 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $927 · 2020: $125 · 2021: $532 · 2022: $1,582 · 2023: $1,739 · 2024: $1,299 · 2025: $1,997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,034.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,095.82 | 2019-2025 | Puraply, Simplimax, Via Matrix |
| Smith+Nephew, INC. | $1,255.44 | 2019-2025 | Oasis Micro, Grafix Pl, Versajet |
| Stryker Corporation | $934.65 | 2019-2024 | Citrefix, Variax, Ortholoc 2 Lapifuse |
| Treace Medical Concepts, INC. | $665.53 | 2019-2025 | |
| Paratek Pharmaceuticals, INC. | $453.46 | 2022-2025 | Nuzyra |
| Integra Lifesciences Corporation | $422.15 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Averitas Pharma INC. | $340.89 | 2023-2025 | Qutenza |
| Solventum Corporation | $327.71 | 2024-2025 | Activ.A.C., V.A.C.Instill, Prevena |
| Kerecis Limited | $183.75 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Vertex Pharmaceuticals Incorporated | $178.68 | 2024-2025 | |
| Paragon 28, INC. | $153.37 | 2022-2024 | Precision Mis Bunion |
| Biocomposites INC | $133.33 | 2025 | Stimulan |
| Abbvie INC. | $127.45 | 2023-2025 | Dalvance |
| Orthofix Medical, INC. | $125.29 | 2025 | Trinity Elite, Physio-Stim |
| Melinta Therapeutics, LLC | $119.20 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $104.00 | 2022 | |
| Alafair Biosciences, INC. | $91.88 | 2024 | Versawrap |
| Nevro Corp. | $71.65 | 2022-2023 | Senza |
| Kci USA, INC. | $68.84 | 2019-2023 | V.A.C. Dermatac, Activ.A.C. |
| Ossio INC | $56.64 | 2023 | |
| Wright Medical Technology, INC. | $55.03 | 2020 | |
| Medtronic, INC. | $45.63 | 2023 | Intellis Adaptivestim |
| Kowa Pharmaceuticals America, INC. | $31.85 | 2023 | Seglentis |
| Paladin Technology Solutions | $29.93 | 2023 | |
| Reapplix INC. | $27.74 | 2022 | |
| Grt US Holding, INC. | $24.61 | 2022 | |
| Tactile Systems Technology INC | $21.16 | 2025 | Flexitouch Plus, Nimbl |
| Sebela Pharmaceuticals INC. | $17.37 | 2023 | Naftin |
| Synergy Orthopedics, LLC | $17.32 | 2023 | |
| Urgo Medical North America, LLC | $15.18 | 2025 | Urgoclean Ag |
| Next Science LLC | $5.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.